Suppr超能文献

相似文献

2
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0.
Eur J Nucl Med Mol Imaging. 2025 Apr;52(5):1822-1839. doi: 10.1007/s00259-024-07038-5. Epub 2025 Jan 7.
6
Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [F]SiTATE.
Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3390-3399. doi: 10.1007/s00259-023-06315-z. Epub 2023 Jun 26.
7
Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma.
Nuklearmedizin. 2020 Sep;59(5):348-355. doi: 10.1055/a-1200-0989. Epub 2020 Jul 20.
8
PET imaging in patients with meningioma-report of the RANO/PET Group.
Neuro Oncol. 2017 Nov 29;19(12):1576-1587. doi: 10.1093/neuonc/nox112.
9
PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATE.
Clin Nucl Med. 2021 Aug 1;46(8):667-668. doi: 10.1097/RLU.0000000000003607.
10
Evaluation of [Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space.
J Nucl Med. 2023 Aug;64(8):1185-1190. doi: 10.2967/jnumed.123.265424. Epub 2023 Jun 29.

引用本文的文献

3
Recent technology development in radiotherapy for intracranial meningiomas.
Front Neurol. 2025 Apr 28;16:1568898. doi: 10.3389/fneur.2025.1568898. eCollection 2025.
5
Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine.
CA Cancer J Clin. 2025 May-Jun;75(3):226-242. doi: 10.3322/caac.70007. Epub 2025 Apr 4.
6
Meningioma: Novel Diagnostic and Therapeutic Approaches.
Biomedicines. 2025 Mar 7;13(3):659. doi: 10.3390/biomedicines13030659.
8
Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors.
J Neuroendocrinol. 2025 Mar;37(3):e70013. doi: 10.1111/jne.70013. Epub 2025 Mar 10.
9
Flip-flop phenomenon on dual SSTR PET and amino acid PET in a case of recurrent meningioma with malignant transformation.
Eur J Nucl Med Mol Imaging. 2025 May;52(6):1939-1941. doi: 10.1007/s00259-024-06998-y. Epub 2024 Nov 26.
10
Do we need dosimetry for the optimization of theranostics in CNS tumors?
Neuro Oncol. 2024 Dec 9;26(Supplement_9):S242-S258. doi: 10.1093/neuonc/noae200.

本文引用的文献

1
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.
Lancet Oncol. 2024 Jan;25(1):e29-e41. doi: 10.1016/S1470-2045(23)00525-9.
3
Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [F]SiTATE.
Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3390-3399. doi: 10.1007/s00259-023-06315-z. Epub 2023 Jun 26.
4
Cost-Effectiveness Analysis of Ga-DOTATATE PET/MRI in Radiotherapy Planning in Patients with Intermediate-Risk Meningioma.
AJNR Am J Neuroradiol. 2023 Jul;44(7):783-791. doi: 10.3174/ajnr.A7901. Epub 2023 Jun 8.
7
68Ga-DOTATOC PET in Extracranial Hepatic and Bone Metastasis of Atypical Refractory Meningioma: A Case Report.
Clin Nucl Med. 2023 Feb 1;48(2):176-178. doi: 10.1097/RLU.0000000000004518.
9
Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [F]SiTATE PET.
EJNMMI Radiopharm Chem. 2022 Sep 5;7(1):22. doi: 10.1186/s41181-022-00176-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验